COMP <GO>
NCI vs MA // RETURN ON INVESTED CAPITAL (ROIC)
Neo-Concept International Group Holdings Limited (Class A) (NASDAQ) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: NCI 1
— MA 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MA
LAST: $0.73 (-1.68%) • MKT CAP: $6.6M
roic
2.60%
LAST: $635.70 (+4.16%) • MKT CAP: $556.88B
roic
33.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NCI VS. MA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NCI | MA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 2.60% | 33.50% | -30.90 | MA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.3x | 29.2x | -19.90 | NCI | /valuation <GO> |
| Free Cash Flow Yield | — | 3.08% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 1.30% | 57.60% | -56.30 | MA | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 45.60% | -45.40 | MA | /net-margins <GO> |
| Revenue Growth (YoY) | -41.90% | 16.40% | -58.30 | MA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | MA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.49 | 11.17 | -9.68 | MA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | MA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 17.7 | 68.8 | -51.06 | MA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 31.2x | +108.80 | MA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.6M | $556.88B | -$556.87B | MA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NCI REV | MA REV | NCI GROSS % | MA GROSS % | NCI FCF | MA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.6M | $32.79B | 36.9% | — | $2.2M | $17.16B |
| FY 2024 | $30.3M | $28.17B | 21.0% | — | -$478.4K | $14.31B |
| FY 2023 | $22.3M | $25.10B | — | — | -$6.3M | $10.85B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NCI // BETA —
MA // BETA 0.90